Allogene Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/13/2025 | 23.77 M | $50.63 M | -20.83% | 11.36% |
| PFIZER INC | 02/14/2025 | 22.03 M | $46.93 M | 100.00% | 10.53% |
| TPG GP A, LLC | 02/14/2025 | 18.72 M | $39.87 M | 0.00% | 8.95% |
| BLACKROCK, INC. | 02/07/2025 | 18.06 M | $38.47 M | 1.63% | 8.63% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/14/2025 | 10.87 M | $23.16 M | 75.33% | 5.20% |
| VANGUARD GROUP INC | 02/11/2025 | 8.00 M | $17.04 M | -3.93% | 3.82% |
| STATE STREET CORP | 02/14/2025 | 7.25 M | $15.44 M | 3.38% | 3.47% |
| CAPITAL WORLD INVESTORS | 02/13/2025 | 6.90 M | $14.69 M | 0.00% | 3.30% |
| CITADEL ADVISORS LLC | 02/14/2025 | 5.35 M | $11.39 M | 6.14% | 2.56% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 4.93 M | $10.50 M | -13.07% | 2.36% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 4.49 M | $9.56 M | -7.30% | 2.14% |
| WOODLINE PARTNERS LP | 02/14/2025 | 4.36 M | $9.29 M | -0.09% | 2.08% |
| JPMORGAN CHASE & CO | 02/12/2025 | 3.74 M | $7.96 M | -8.60% | 1.79% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 3.56 M | $7.59 M | 30.44% | 1.70% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 3.45 M | $7.34 M | 100.00% | 1.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.23 M | $6.89 M | 0.17% | 1.55% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 01/29/2025 | 2.92 M | $6.22 M | 0.00% | 1.40% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 2.87 M | $6.11 M | 0.00% | 1.37% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 2.71 M | $5.78 M | -3.07% | 1.30% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 2.70 M | $5.76 M | 12.11% | 1.29% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.11 M | $4.49 M | -2.59% | 1.01% |
| VIDA VENTURES ADVISORS, LLC | 01/21/2025 | 1.80 M | $3.83 M | 0.00% | 0.86% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.50 M | $3.20 M | 0.00% | 0.72% |
| PATIENT SQUARE CAPITAL LP | 02/14/2025 | 1.49 M | $3.17 M | 100.00% | 0.71% |
| NORTHERN TRUST CORP | 02/14/2025 | 1.31 M | $2.78 M | 4.54% | 0.62% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.24 M | $2.64 M | 18.09% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.19 M | $2.53 M | 0.85% | 0.57% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 1.16 M | $2.48 M | 99.30% | 0.56% |
| GILEAD SCIENCES, INC. | 02/13/2025 | 1.16 M | $2.46 M | 100.00% | 0.55% |
| MORGAN STANLEY | 02/14/2025 | 998,596 | $2.13 M | -41.99% | 0.48% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 849,658 | $1.81 M | 1,732.19% | 0.41% |
| UBS GROUP AG | 02/14/2025 | 796,491 | $1.70 M | 129.31% | 0.38% |
| BARCLAYS PLC | 02/13/2025 | 761,286 | $1.62 M | 121.97% | 0.36% |
| CITIGROUP INC | 02/12/2025 | 716,236 | $1.53 M | 52.61% | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 554,541 | $1.18 M | -13.62% | 0.27% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 545,388 | $1.16 M | -19.46% | 0.26% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 484,715 | $1.03 M | -0.27% | 0.23% |
| ZACKS INVESTMENT MANAGEMENT | 02/13/2025 | 480,874 | $1.02 M | -6.92% | 0.23% |
| NORDEA INVESTMENT MANAGEMENT AB | 01/06/2025 | 460,641 | $985,772 | 2.14% | 0.22% |
| 02/14/2025 | 430,000 | $903,000 | 100.00% | 0.21% | |
| CERITY PARTNERS LLC | 02/13/2025 | 387,387 | $831,567 | -10.41% | 0.19% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 376,661 | $802,288 | 100.00% | 0.18% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 367,445 | $782,658 | 15.93% | 0.18% |
| ABRDN PLC | 01/24/2025 | 364,382 | $776,134 | 100.00% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 330,769 | $704,539 | 4.14% | 0.16% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 305,895 | $651,120 | 23.56% | 0.15% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 300,871 | $640,855 | 18.34% | 0.14% |
| SWISS NATIONAL BANK | 02/10/2025 | 287,900 | $613,227 | 8.68% | 0.14% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 270,559 | $576,291 | 18.25% | 0.13% |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 02/12/2025 | 253,576 | $547,724 | 7.13% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Allogene Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 200 institutional investors and hedge funds held shares of Allogene Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 23.77 M
PFIZER INC: 22.03 M
TPG GP A, LLC: 18.72 M
BlackRock, Inc.: 18.06 M
Lynx1 Capital Management LP: 10.87 M
VANGUARD GROUP INC: 8 M
90.07% of Allogene Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 226.19 M shares in the last 24 months. This purchase volume represents approximately $325.71 M in transactions.